Novel Blood Cytokine-Based Model for Predicting Severe Acute Kidney Injury and Poor Outcomes After Cardiac Surgery.

Zhongli Chen,Liang Chen,Guangyu Yao,Wenbo Yang,Ke Yang,Chenglong Xiong

DOI: https://doi.org/10.1161/jaha.120.018004

IF: 6.106

2020-11-03

Journal of the American Heart Association

Abstract:Background Alterations in serum creatinine levels delay the identification of severe cardiac surgery‐associated acute kidney injury. To provide timely diagnosis, novel predictive tools should be investigated. Methods and Results This prospective observational study consists of a screening cohort (n=204) and a validation cohort (n=198) from 2 centers from our hospital. Thirty‐two inflammatory cytokines were measured via a multiplex cytokine assay. Least absolute shrinkage and selection operator regression was conducted to select the cytokine signatures of severe cardiac surgery‐associated acute kidney injury. Afterwards, the significant candidates including interferon‐γ, interleukin‐16, and MIP‐1α (macrophage inflammatory protein‐1 alpha) were integrated into the logistic regression model to construct a predictive model. The predictive accuracy of the model was evaluated in these 2 cohorts. The cytokine‐based model yielded decent performance in both the screening (C‐statistic: 0.87, Brier 0.10) and validation cohorts (C‐statistic: 0.86, Brier 0.11). Decision curve analysis revealed that the cytokine‐based model had a superior net benefit over both the clinical factor‐based model and the established plasma biomarker‐based model for predicting severe acute kidney injury. In addition, elevated concentrations of each cytokine were associated with longer mechanical ventilation times, intensive care unit stays, and hospital stays. They strongly predicted the risk of composite events (defined as treatment with renal replacement therapy and/or in‐hospital death) (OR of the fourth versus the first quartile [95% CI]: interferon‐γ, 27.78 [3.61–213.84], interleukin‐16, 38.07 [4.98–291.07], and MIP‐1α, 9.13 [2.84–29.33]). Conclusions Our study developed and validated a promising blood cytokine‐based model for predicting severe acute kidney injury after cardiac surgery and identified prognostic biomarkers for assisting in outcome risk stratification. Nonstandard Abbreviations and Acronyms AKI acute kidney injury CSA‐AKI cardiac surgery‐associated acute kidney injury ICU intensive care unit Clinical Perspective What Is New? Patients who developed severe acute kidney injury after cardiac surgery had distinct blood immune‐inflammatory cytokines signatures within 12 to 24 hours after surgery. A novel cytokine‐based predictive model incorporating interferon‐γ, interleukin‐16, and MIP‐1α (macrophage inflammatory protein‐1 alpha) successfully predicted severe cardiac surgery‐associated ‐acute kidney injury). Interferon‐γ, interleukin‐16, and MIP‐1α were all capable of predicting poor outcomes after cardiac surgery. What Are the Clinical Implications? Increased plasma concentrations of interferon‐γ, interleukin‐16, and MIP‐1α each predict higher risk for severe cardiac surgery‐associated‐acute kidney injury. Alterations in plasma immune‐inflammatory cytokine concentrations demonstrate promise for early identification of patients likely to develop severe cardiac surgery‐associated‐acute kidney injury. Acute kidney injury (AKI) is one of the major adverse complications frequently occurring after cardiac surgery. 1 Globally, ≈5% to 42% of patients undergoing cardiac surgery experience AKI. 2 Patients with severe AKI are confronted with a 3‐ to 8‐fold higher perioperative mortality, prolonged length of intensive care unit (ICU) and hospital stay, and an increased cost of health care. 3 Moreover, as reported, cardiac surgery‐associated acute kidney injury (CSA‐AKI) was the second leading condition for AKI in the intensive care setting and contributed to increased mortality. 4 Currently, because of a general lack of effective treatments for severe CSA‐AKI, the earlier identification of the condition will offer clinicians essential guidance on the prevention and management of the syndrome. Given that traditional clinical diagnosis based on serum creatinine alterations and clinical risk facto -Abstract Truncated-

cardiac & cardiovascular systems